AI Is About to Simulate Human Biology

Can AI become a universal simulator of biology, helping predict disease, improve drug success rates, and reshape how medicine is developed? A thoughtful conversation on AI, biology, and the future of medicine. From lessons learned in big tech to what it takes to build enduring platforms in TechBio, this is a considered discussion for anyone interested in where scientific discovery is heading.

This week on Leading Beyond The Lab, Lawrence Rose sat down with Jean-Philippe Vert, Co-Founder and CEO of Bioptimus, with decades of experience spanning artificial intelligence, computational biology, academia and big tech, including leadership roles at Google, and work influenced by breakthroughs such as DeepMind’s AlphaFold.In this episode, Jean-Philippe covers:
• Why Bioptimus is focused on understanding patient biology, not simply designing molecules, and why that could change drug development.
• How AI-powered decision systems could improve translational research, clinical trial design, patient recruitment and disease prediction.
• Why Jean-Philippe left Google to build Bioptimus, and why foundation models for biology may represent a major shift in medicine.
• How partnerships across healthcare systems, pharma and research institutions are helping build the data infrastructure behind biological foundation models, with perspectives shaped alongside leaders including Sarah Teichmann (Professor at Cambridge University) and Caroline Uhler (Professor at MIT)
• What makes AI in biology defensible, from proprietary data partnerships and elite interdisciplinary teams, to support from investors including Edward Kliphuis (Sofinnova Partners), Bpifrance, Cathay Investments.

More videos like this:

Rewriting Rare Disease R&D with Foundation Models

Join our CEO Jean-Philippe Vert on the RARECast podcast to discover how we are using foundation models to rewrite rare disease R&D and repurpose existing drugs .

Bridging the Gap: Bioptimus CEO Jean-Philippe Vert on Building the Foundational AI for Biology

In this deep-dive episode of the Empowered Paient Podcast, Jean-Philippe explains why understanding biology across all scales—from molecules to organs—is the key to unlocking the next generation of precision medicine.

Mathilda Strom, Founding COO @Bioptimus | Slush 2024

At Slush 2024, our Founding COO Mathilda Strom took the stage to unveil how we at Bioptimus are building the world's first multiscale, multimodal foundation model for biology.

AI in Healthcare: Scaling Drug Discovery & Clinical Trials

Join our Founding COO Mathilda Strom on the Startup Scaleup People podcast to explore how we are using AI to fix the 90% clinical trial failure rate. In this episode, Mathilda shares insights from her 20-year career in scaling high-impact ventures and explains why Bioptimus is a different kind of deep-tech challenge.

Inside Bioptimus: Training (and Tracking) Foundation Models for Biology

Discover how we at Bioptimus track and refine our foundation models for biology, to make them learn the language of life so they can help you accelerate drug discovery and compress development timelines.

Bioptimus COO Mathilda Strom on AI, Compute, and the Future of Biological Foundation Models

Mathilda Strom, the Founding COO at Bioptimus, shares her journey from building startups across Africa, Asia, and Latin America to helping shape one of the most ambitious AI and biology projects on the planet.

Foundation Models for Biology, Across Scales

Discover how AI foundation models are revolutionising biology and drug discovery. Jean-Philippe Vert explores the future of multiscale virtual cells.

Mathilda Strom, Founding COO @Bioptimus | Slush 2024

Slush is a founder-focused annual event delivering actionable company-building advice while bringing together the who’s who in startups and tech.

Building an AI model for Biology

Could AI unlock the secrets of biology? In this WIRED Health 2025 Startup Pitch, Zelda Mariet, Principal Research Scientist and Co-Founder of Bioptimus, introduces their groundbreaking universal AI foundation model that connects biology at every scale - from molecules to cells, tissues, and organisms.